Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 491-500 of 538 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. DNA and RNA Testing in Patients With Hereditary Cancer Syndromes

    Rochester, MN

  2. Melanoma In-transit Tissue Bank and Molecular Analysis for Personalized Therapies

    Rochester, MN, Jacksonville, FL

  3. Tumor Infiltrating Lymphocytes Biobank

    Rochester, MN

  4. The Impact of a Geriatric Assessment in Elderly Patients with Multiple Myeloma

    Rochester, MN

  5. Perfusion MRI for Therapy Response Assessment in Brain Cancer

    Scottsdale/Phoenix, AZ

  6. Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease

    Rochester, MN, Jacksonville, FL

  7. Hairy Cell Leukemia Patient Data Registry

    Rochester, MN

  8. Cell Saver During Tumor Resection

    Rochester, MN

  9. Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer, the ENHANCE Study

    Rochester, MN

  10. A study of how current treatments impact the course of relapsed myeloma and the effect of the treatments on the quality-of-life measurements.

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer